Here are relevant reports on : parenteral-nutrition-market
-
IV Equipment Market by Type (IV Catheter, IV Administration Set, Needle-free Connectors), Application (Medication Administration, Parenteral Nutrition, Diagnostic Testing, Blood & Blood Product Transfusion), End User (Hospital) - Global Forecast to 2031
The IV Equipment market, valued at USD 16.85 billion in 2025, stood at USD 17.82 billion in 2026 and is projected to advance at a resilient CAGR of 6.1% from 2026 to 2031, culminating in a forecasted valuation of USD 23.92 billion by the end of the period. The IV equipment market is expected to grow significantly, driven by increasing cases of chronic diseases, rising hospitalizations, and an aging population.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Specialty Fats & Oils Market by Type (Specialty Fats & Specialty Oils), Application (Chocolate & Confectionery, Bakery Product, Processed Food, Animal Nutrition, Dairy Product, and Infant Nutrition), Form (Dry & Liquid), & Region - Global Forecast to 2026
The market for specialty fats and oils is expected to grow USD 19.8 billion by 2026 at a CAGR of 7.8% during the forecasting period. The major vendors in the global specialty fats and oils market are Cargill Incorporated (US), Wilmar International (Singapore), Bunge Limited (US), Mewah International (Singapore), and AAK AB (Sweden).
- Published: September 2020
- Price: $ 4950
- TOC Available:
-
Lipid Nutrition Market (Nutritional Lipids) by Type (Omega-3, Omega-6, MCTs), Source, Form, Application (Dietary Supplements & Nutraceuticals, Infant Formula, Pharmaceuticals, Food Fortification, Animal Nutrition), and Region - Global Forecast to 2022
The global lipid nutrition market was valued at USD 6.51 Billion in 2016, and is projected to reach USD 11.15 Billion by 2022, at a CAGR of 9.4% during the forecast period. This report includes a study of the product offerings and competitive benchmarking of leading companies. It includes the profiles of leading companies such as Koninklijke DSM N.V. (Netherlands), BASF SE (Germany), Nordic’s Naturals, Inc. (U.S.), Croda International Plc (U.K.), Archer Daniels Midland Company (U.S.), Kerry Group plc (Ireland), FMC Corporation (U.S.), Neptune Wellness Solutions (Canada), Aker BioMarine AS (Norway), Omega Protein Corporation (U.S.), FrieslandCampina (Netherlands), and Polaris Nutritional Lipids (France).
- Published: July 2017
- Price: $ 4950
- TOC Available:
-
Compounding Pharmacy Market by Product (Oral, Topical, Parenteral), Compounding Type (Ingredient Alteration, Dosage Alteration), Therapeutic Application (Pain Management, HRT), Sterility (Sterile), End User (Pediatric, Adult) - Global forecast to 2030
The global Compounding Pharmacy market, valued at US$13.48 billion in 2024, stood at US$14.72 billion in 2025 and is projected to advance at a resilient CAGR of 5.7% from 2025 to 2030, culminating in a forecasted valuation of US$19.41 billion by the end of the period.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Veterinary Pain Management Market by Product (Drug (NSAIDs, Opioids), Route of Administration (Oral, Parenteral), Device (Laser)), Application (Joint Pain, Cancer), Animal (Companion and Livestock), End User (Hospital, Pharmacy) - Global Forecast to 2027
Veterinary pain management market growth is primed to transition from $1.8 billion in 2022 to $2.5 billion by 2027, showcasing a strong CAGR of 6.7%. Factors such as growth in companion animal adoption, the increasing number of veterinary practitioners and their rising income levels in developed economies, increasing consumption of meat & milk, the growing prevalence of animal disease causing pain and inflammation, and rising adoption of pet insurance with growing animal health expenditure are expected to drive the growth of this market.
- Published: September 2022
- Price: $ 4950
- TOC Available:
-
Pharmaceutical Excipients Market by Product ((Organic (Oleochemicals, Cellulose, Glycols), Inorganic)), Functionality (Fillers & Diluents, Binders, Lubricants), Formulation (Oral, Parenteral), Functionality Application (Stabilizers) - Global Forecast to 2030
The global pharmaceutical excipients market, valued at US$10.5 billion in 2024, stood at US$11.0 billion in 2025 and is projected to advance at a resilient CAGR of 6.1% from 2025 to 2030, culminating in a forecasted valuation of US$14.9 billion by the end of the period. Growing demand for pharmaceutical products and generic medications, along with increasing investments in research and development for innovative excipient formulations, are key drivers fueling market expansion
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Vitamin D Therapy Market by Route of administration (Oral, Parenteral), Age Group (Children, Adult, Senior Adult), Purchase Pattern (OTC, Prescription), Application (Osteoporosis, Rickets, Autoimmune Disorder, Skin Diseases) - Global Forecast to 2024
The vitamin D therapy market is projected to reach USD 3.3 billion by 2024 from USD 1.9 billion in 2019, at a CAGR of 11.6% during the forecast period. Growth in this market is largely driven by the growing awareness about vitamin D deficiency and the presence of a large target patient population. On the other hand, the fortification of foods is likely to challenge the growth of this market. Some of the major players in this market include Abbott (US), Sanofi (France), GlaxoSmithKline plc (UK), Pfizer Inc. (US), Merck & Co., Inc. (US), Torrent Pharmaceuticals Ltd. (India), Novartis International AG (Switzerland), Alkem Laboratories (India), Sun Pharmaceutical Industries Ltd. (India), and Cadila Healthcare Ltd. (India).
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
Pharmaceutical Inspection Machines Market by Component ((Vision Inspection, X-Ray, Checkweigher, Metal Detector), Software), Type (Manual, Automatic), Packaging Type (Syringe, Blister, Bottle), Formulation (Parenteral, Oral) - Global Forecast to 2029
The global pharmaceutical inspection machines market, valued at US$0.9 billion in 2023, stood at US$0.9 billion in 2024 and is projected to advance at a resilient CAGR of 7.6% from 2024 to 2029, culminating in a forecasted valuation of US$1.4 billion by the end of the period. The major factors driving the pharmaceutical inspection machines growth are increasing use of inspection machines by pharmaceutical and biotechnology companies, increasing number of inspection checkpoint mandates in pharmaceutical products, and rise in pharmaceutical outsourcing in emerging economies.
- Published: July 2024
- Price: $ 4950
- TOC Available:
-
Pharmaceutical Contract Manufacturing Market by Service (Drug Development, Pharmaceutical (API, FDF - Parenteral, Tablet, Capsule), Biologics (API, FDF), Packaging & Labelling, Fill-finish), Molecule (Small, Large (ADC, CGT)) - Global Forecast to 2030
The global pharmaceutical contract manufacturing market, valued at US$193.52 billion in 2024, stood at US$209.90 billion in 2025 and is projected to advance at a resilient CAGR of 8.2% from 2025 to 2030, culminating in a forecasted valuation of US$311.95 billion by the end of the period. This is mainly due to the high demand for outsourcing services for GLP-1 manufacturing, the growing ADC outsourcing for commercialized products, and the development and patent expiry of blockbuster biologics, which are paving the way for key biosimilars.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Osteoarthritis Therapeutics Market by Anatomy (Knee, Hand), Drug Type (NSAIDs, Analgesics, Corticosteroids), Route of Administration (Parenteral), Distribution Channel (Hospital Pharmacies), Purchasing Pattern (Prescription Drugs) - Global Forecasts to 2025
The global osteoarthritis therapeutics market growth is primed to transition from USD 7.3 billion in 2020 to USD 11.0 million by 2025, showcasing a strong CAGR of 8.7%.
- Published: December 2020
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
